Table 4 Clinical characteristics and CT findings for validation cohort
Features | HP masses (n = 16) | STs(n = 16) | P Value |
|---|---|---|---|
Age(year) | 43.56 ± 12.49 | 57.51 ± 7.49 | 0.001a |
Location (the lower part/other) | 12/4 | 1/15 | < 0.001 |
Border (ill defined/ well defined) | 10/6 | 4/12 | 0.033 |
Contour (flat or hill-like/other) | 6/10 | 1/15 | 0.026 |
Enhancement grade (marked/ other) | 13/3 | 2/14 | 0.001 |
CT enhancement value (> 27.50 HU/< 27.50 HU) | 13/3 | 5/11 | 0.004 |
Relative enhancement ratio (> 0.66/< 0.66) | 13/3 | 4/12 | 0.001 |
Relative enhancement ratio to pancreas (> 0.72/< 0.72) | 13/3 | 6/10 | 0.012 |
LD/SD(> 1.29/< 1.29) | 12/4 | 6/10 | 0.033 |